SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Lux Biosciences, Isotechnika Pharma Inc. Receive Complete Response Letter from FDA for Voclosporin; FDA Requests Additional Information and Clinical Trial; Isotechnika Shares Dive 32.56% at 1:22PM EDT